 | Up a level |
Journal Article
Popat, S., Ardizzoni, A., Ciuleanu, T., Cobo Dols, M., Laktionov, K., Szilasi, M., Califano, R., Carcereny Costa, E., Griffiths, R., Paz-Ares, L., Szczylik, C., Corral, J., Isla, D., Jassem, J., Appel, W., Van Meerbeeck, J., Wolf, J., Jiang, J., Molife, L. R. and Felip Font, E. (2017). Nivolumab in previously treated patients with metastatic squamous NSCLC: Results of a European single-arm, phase 2 trial (CheckMate 171) including patients aged >= 70 years and with poor performance status. Ann. Oncol., 28. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Reck, M., Vicente, D., Ciuleanu, T., Gettinger, S., Peters, S., Horn, L., Audigier-Valette, C., Pardo, N., Juan-Vidal, O., Cheng, Y., Zhang, H., Shi, M., Wolf, J., Antonia, S. J., Nakagawa, K., Selvaggi, G., Baudelet, C., Chang, H. and Spigel, D. R. (2018). Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331. Ann. Oncol., 29. S. 43 - 44. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041